Society for Participatory Medicine

FEBRUARY 1, 2023

Our honeymoon commenced in April with what some pharmaceutical sponsors refer to as a “mandate” to show proof of a diversity, equity, and inclusion plan “as soon as practical” in the new drug application process, further solidified by the passage of the omnibus spending package at the end of 2022.

BioTech 144

BioTech Drug Development Meaningful Use Pharmaceuticals 144

Healthcare IT Today

JANUARY 8, 2024

It is key for pharmaceutical companies to recognize that efficiency does not override compliance, patient safety or regulatory standards. Health Economics Outcomes Research (HEOR) will become more common in decentralized clinical trials (DCTs). Dave Latshaw, CEO at BioPhy 1.

Health IT 81

Health IT Drug Development Pharmaceuticals BioTech 81

Health Populi

APRIL 24, 2019

I analyzed those general results with health/care implications here in Health Populi. In this study, the healthcare industry is comprised of five segments: hospitals and clinics; pharma; biotech (separate from pharma); consumer health (e.g., over-the-counter medicines); and, health insurance.

BioTech 205

BioTech Pharmaceuticals Life Science Health Information 205

Lloyd Price

SEPTEMBER 2, 2023

This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies. Drug discovery and development: This includes companies that use digital health technologies to develop new drugs and treatments.

Life Science 64

Life Science Digital Health EHR BioTech 64

Health Populi

JANUARY 9, 2020

The Digital Health Summit at CES collaborated with Kantar on a poll gauging peoples’ perspectives on trust , technology and health. While most consumers say technology enables us to be connected with our health care, trust is a barrier to digital engagement. adults conducted in November 2019.

BioTech 170

BioTech Pharmaceuticals Digital Health Nursing 170